Internally administered therapeutic agents for cranial nerve diseases comprising mesenchymal cells as an active ingredient
    3.
    发明申请
    Internally administered therapeutic agents for cranial nerve diseases comprising mesenchymal cells as an active ingredient 有权
    包含间充质细胞作为活性成分的颅神经疾病的内用药治疗剂

    公开(公告)号:US20080286246A1

    公开(公告)日:2008-11-20

    申请号:US12149646

    申请日:2008-05-06

    IPC分类号: A61K35/12 A61P7/00

    摘要: Intravenous administration of bone marrow cells collected from rat bone marrow or peripheral blood to a rat cerebral infarction model was found to be effective in treating cerebral infarction. Human and murine bone marrow stem cells showed similar effects. Mesenchymal cells such as bone marrow cells, cord blood cells, or peripheral blood cells can be used as agents for in vivo administration against cranial nerve diseases.

    摘要翻译: 从大鼠骨髓或外周血中收集的大鼠脑梗死模型的静脉内给药可以有效治疗脑梗死。 人和鼠骨髓干细胞表现出相似的效果。 间充质细胞如骨髓细胞,脐带血细胞或外周血细胞可用作用于体内施用针对颅神经疾病的试剂。

    Internally administered therapeutic agents for cranial nerve diseases comprising mesenchymal cells as an active ingredient
    4.
    发明申请
    Internally administered therapeutic agents for cranial nerve diseases comprising mesenchymal cells as an active ingredient 审中-公开
    包含间充质细胞作为活性成分的颅神经疾病的内用药治疗剂

    公开(公告)号:US20060210544A1

    公开(公告)日:2006-09-21

    申请号:US11377610

    申请日:2006-03-17

    IPC分类号: A61K48/00 C12N5/08

    摘要: Intravenous administration of bone marrow cells collected from rat bone marrow or peripheral blood to a rat cerebral infarction model was found to be effective in treating cerebral infarction. Human and murine bone marrow stem cells showed similar effects. Mesenchymal cells such as bone marrow cells, cord blood cells, or peripheral blood cells can be used as agents for in vivo administration against cranial nerve diseases.

    摘要翻译: 从大鼠骨髓或外周血中收集的大鼠脑梗死模型的静脉内给药可以有效治疗脑梗死。 人和鼠骨髓干细胞表现出相似的效果。 间充质细胞如骨髓细胞,脐带血细胞或外周血细胞可用作用于体内施用针对颅神经疾病的试剂。

    Therapeutic autologous-cell delivery support system, financial system for use therewith, and method therefor
    7.
    发明申请
    Therapeutic autologous-cell delivery support system, financial system for use therewith, and method therefor 审中-公开
    治疗性自体细胞递送支持系统,其使用的金融系统及其方法

    公开(公告)号:US20060062771A1

    公开(公告)日:2006-03-23

    申请号:US11231521

    申请日:2005-09-19

    IPC分类号: G06F19/00

    摘要: Disclosed is a therapeutic autologous-cell delivery support system 100, in which a therapeutic autologous cell extracted from a member is reserved in reserve means 34, and an autologous-cell delivery request from the member which includes ID information and positional information is received. Membership information is retrieved in accordance with the received ID information, and the membership information and positional information of the member is output. When the reserve means is provided in plural number at geographically different locations, one reserve means having a shortest delivery time is selected in accordance with the positional information included in the delivery request. The delivery request can be issued using ID information storage means 11 for transmitting the ID information, in a simple operation, or automatically issued using a monitor of physical data.

    摘要翻译: 公开了一种治疗性自体 - 细胞递送支持系统100,其中从保留装置34保留从成员提取的治疗性自体细胞,并且接收到来自成员的包含ID信息和位置信息的自体细胞递送请求。 根据接收到的ID信息检索会员信息,输出会员信息和会员的位置信息。 当在地理上不同的位置上设置多个保留装置时,根据包括在传送请求中的位置信息来选择具有最短传送时间的一个保留装置。 可以使用用于发送ID信息的ID信息存储装置11在简单的操作中发布或者使用物理数据的监视器自动发出发送请求。